Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy

• KIM Kee-Sik

  Department of Internal Medicine, Daegu Catholic University Medical Center

• FAN Wei Hu

  Department of Internal Medicine, Huashan Hospital

• KIM Young-Dae

  Department of Internal Medicine, Dong-A University Hospital

• ZHU Wenling

  Department of Internal Medicine, Peking Union Medical College Hospital

• NGAU Yen Yew

  Department of Internal Medicine, Hospital Kuala Lumpur

• TONG Peter

  Department of Internal Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong

• KIM Byung-Soo

  Department of Internal Medicine, Dae-Dong Hospital

• SANTOS Maureen

  Department of Internal Medicine, Cebu Doctors' University Hospital

• LIN Wei-Hsiang

  Department of Internal Medicine, Tri-Service General Hospital

• BURANAKITJAROEN Peera

  Department of Internal Medicine, Siriraj Hospital, Mahidol University

• MASSAAD Rachid

  MSD (Europe) Inc.

• SMITH Ronald D

  Merck and Co. Inc.

収録刊行物

• Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension

  Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 32 (6), 520-526, 2009-06-01

キーワード

• angiotensin-converting enzyme inhibitors
• angiotensin receptor blockers
• Asian patients
• combination therapy
• hypertension treatment
• losartan
• hydrochlorothiazide combination

詳細情報

• CRID: 1573105975533137920
• NII論文ID: 10024831380
• NII書誌ID: AA10847079
• ISSN: 09169636
• 本文言語コード: en
• データソース種別:
  • CiNii Articles